Research Overview
Across the provided abstracts, research related to belladonna (Atropa spp.) is most developed in three areas: (1) toxicology and clinical management of poisoning from tropane-alkaloid–containing plants (including belladonna), (2) pharmacology and clinical use of isolated belladonna alkaloids—especially scopolamine—as standardized medicines, and (3) analytical/quality-control considerations for botanical products where marker compounds (e.g., atropine/scopolamine) are used to assess identity and content. A smaller, more exploratory body of work extends to plant-derived materials and derivatives (e.g., Atropa acuminata leaf-extract–mediated silver nanoparticles) evaluated in preclinical assays for antioxidant, anticancer, anti-inflammatory, and vector-control activity, though these studies are not equivalent to evidence for clinical efficacy of belladonna preparations.
The strongest evidence in these abstracts supports well-characterized, standardized alkaloids rather than whole-plant belladonna products. In particular, transdermal scopolamine has consistent clinical-trial evidence for safety and efficacy in preventing postoperative nausea and vomiting (PONV), aligning with its established mechanism as a non-selective muscarinic antagonist with central antiemetic effects. Separately, the poisoning literature provides strong evidence that belladonna is a clinically important cause of pediatric plant intoxication and that recognition of the anticholinergic toxidrome and appropriate management—including consultation with poison information centers and, in selected cases, use of physostigmine—are central to care. Evidence for broader “neurological” benefits of plant-derived compounds is presented at the review level but remains general rather than specific, clinically validated support for belladonna itself.
Key gaps include: rigorous clinical studies evaluating efficacy and safety of belladonna herbal preparations (as distinct from purified alkaloids), improved standardization/quality-control frameworks that link chemical markers to clinically meaningful outcomes, and stronger epidemiologic/clinical datasets to guide evidence-based management of belladonna and related tropane-alkaloid poisonings. For emerging applications (e.g., Atropa-mediated nanoparticle synthesis and bioactivity), further work is needed to clarify active constituents, mechanisms, reproducibility, dose–response relationships, and translational relevance, including toxicology and human data before any therapeutic claims can be supported.
Research Overview
The published research on homeopathic Belladonna appears to be sparse and is dominated by clinical safety observations rather than controlled efficacy studies. The most directly studied area in the study is ophthalmic adverse effects associated with over-the-counter homeopathic preparations that list Atropa belladonna (deadly nightshade) as an ingredient. This case report links use of a belladonna-containing “homeopathic” eye drop to an episode of acute angle-closure glaucoma, emphasizing the clinical relevance of supplement/OTC product histories and the potential for physiologically active constituents to produce pharmacologic effects.
The strongest evidence supported by the available abstract is not for therapeutic benefit, but for potential harm: belladonna-containing products can plausibly precipitate acute angle closure in susceptible individuals, consistent with known anticholinergic/mydriatic effects of belladonna alkaloids that can narrow the anterior chamber angle and raise intraocular pressure. However, the evidentiary strength is limited by the design (single-patient case report), which can suggest an association and biological plausibility but cannot establish incidence, causality with high certainty, or risk magnitude across populations and formulations.
Key research gaps include: (1) systematic pharmacologic characterization of “homeopathic” belladonna products (actual alkaloid content, batch variability, and dose delivered via ocular administration), (2) epidemiologic studies to estimate frequency of adverse ocular events and identify high-risk subgroups (e.g., anatomically narrow angles, older adults), and (3) higher-quality clinical evidence on claimed benefits, since the provided literature does not address efficacy outcomes. Additional work on labeling accuracy, regulatory oversight, and clinician/patient education would also help clarify real-world exposure and prevent avoidable adverse events.
1. What conditions has Homeopathic Belladonna been studied for?
Acute angle-closure glaucoma (AACG) precipitated by use of a homeopathic belladonna-containing eye drop (reported as an adverse event/trigger rather than a therapeutic indication).
The study is a single case report describing AACG occurring after use of an over-the-counter homeopathic eye drop whose primary ingredient was Atropa belladonna.
2. Does it work in treating those conditions? Summarize the evidence.
No evidence of therapeutic benefit is provided in the study for treating any condition.
The study instead reports a harm signal: a temporal association between starting belladonna-containing homeopathic eye drops and developing AACG (elevated intraocular pressure, corneal haze, urgent ophthalmology referral).
Because this is a single case report, it cannot establish causality or quantify risk, but it does not support effectiveness for treatment. It supports the possibility of clinically meaningful pharmacologic effects (i.e., not inert) in at least some “homeopathic” preparations.
3. What health benefits does it have?
No health benefits are demonstrated in the study.
The case report does not describe symptom improvement or any positive clinical outcome attributable to homeopathic belladonna; it focuses on a serious adverse outcome after use.
4. Does it have any downsides or side effects?
Potential to precipitate acute angle-closure glaucoma when used as an eye drop containing belladonna: the patient developed unilateral AACG shortly after starting the product, with elevated intraocular pressure and corneal haze.
Risk of vision-threatening harm: AACG is described as “sight-threatening” and potentially leading to blindness if not promptly recognized and treated.
Diagnostic/clinical risk: the report emphasizes the need for careful medication/supplement history because OTC “homeopathic” products may contain physiologically active substances.
Limitations: the evidence here is from a single case report, so it cannot determine how often this occurs or identify which patient factors (e.g., narrow anterior chamber angles) increase susceptibility. Nonetheless, the reported event is severe and biologically plausible given belladonna’s anticholinergic properties (which can dilate the pupil and, in predisposed eyes, trigger angle closure).
5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?
No pharmacogenomic data are provided in the study.
Based on the provided evidence, there are no reported genetic variants that predict benefit or harm from homeopathic belladonna. The described risk appears related to ocular anatomy/physiology and exposure to a pharmacologically active ingredient rather than documented genetic differences.
References
-
Quality Control of Herbal Medicines: From Traditional Techniques to State-of-the-art Approaches.
Luiz C Klein-Junior, Maira R de Souza, Johan Viaene, Tania M B Bresolin, André L de Gasper, Amélia T Henriques, Yvan Vander Heyden (2021) - Planta medica -
Plants' Impact on the Human Brain-Exploring the Neuroprotective and Neurotoxic Potential of Plants.
Georgiana Moise, Alex-Robert Jîjie, Elena-Alina Moacă, Iasmina-Alexandra Predescu, Cristina Adriana Dehelean, Alina Hegheș, Daliborca Cristina Vlad, Roxana Popescu, Cristian Sebastian Vlad (2024) - Pharmaceuticals (Basel, Switzerland) -
Green synthesis of silver nanoparticles using Indian Belladonna extract and their potential antioxidant, anti-inflammatory, anticancer and larvicidal activities.
Shubhra Rajput, Dinesh Kumar, Veena Agrawal (2020) - Plant cell reports -
Antispasmodic Potential of Medicinal Plants: A Comprehensive Review.
Abdur Rauf, Muhammad Akram, Prabhakar Semwal, Adil A H Mujawah, Naveed Muhammad, Zerfishan Riaz, Naveed Munir, Dmitry Piotrovsky, Irina Vdovina, Abdelhakim Bouyahya, Charles Oluwaseun Adetunji, Mohammad Ali Shariati, Zainab M Almarhoon, Yahia N Mabkhot, Haroon Khan (2021) - Oxidative medicine and cellular longevity -
Poisoning by Plants.
Sebastian Wendt, Christoph Lübbert, Kathrin Begemann, Dagmar Prasa, Heike Franke (2022) - Deutsches Arzteblatt international -
The effect of transdermal scopolamine for the prevention of postoperative nausea and vomiting.
María A Antor, Alberto A Uribe, Natali Erminy-Falcon, Joseph G Werner, Keith A Candiotti, Joseph V Pergolizzi, Sergio D Bergese (2014) - Frontiers in pharmacology -
Oral antihistamine-decongestant-analgesic combinations for the common cold.
An Im De Sutter, Lars Eriksson, Mieke L van Driel (2022) - The Cochrane database of systematic reviews -
Atropa belladonna neurotoxicity: Implications to neurological disorders.
Gunnar F Kwakye, Jennifer Jiménez, Jessica A Jiménez, Michael Aschner (2018) - Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association -
Impact of Bias in Data Collection of COVID-19 Cases.
Raj Kumar Manchanda, Anjali Miglani, Moumita Chakraborty, Baljeet Singh Meena, Kavita Sharma, Meeta Gupta, Ashok Sharma, Vishal Chadha, Purnima Rani, Rahul Kumar Singh, Lex Rutten (2022) - Homeopathy : the journal of the Faculty of Homeopathy -
Atropa belladonna intoxication: a case report.
Mohamed Adnane Berdai, Smael Labib, Khadija Chetouani, Mustapha Harandou (2012) - The Pan African medical journal -
Phytochemica: a platform to explore phytochemicals of medicinal plants.
Shivalika Pathania, Sai Mukund Ramakrishnan, Ganesh Bagler (2015) - Database : the journal of biological databases and curation -
Complementary and Alternative Medicines in Oral Health Care: An Integrative Review.
Basem Mohammed Abuzenada, Fawaz Pullishery, Mohamed Samir Abdelmagid Elnawawy, Samaher Abdullah Alshehri, Rowayda Mohammed Basheer Alostath, Batool Mabrook Bakhubira, Walaa Farhan Amerdash (2021) - Journal of pharmacy & bioallied sciences -
Methyl-β-cyclodextrin and coronatine as new elicitors of tropane alkaloid biosynthesis in Atropa acuminata and Atropa belladonna hairy root cultures.
Farnoosh Fattahi, Abdolali Shojaeiyan, Javier Palazon, Elisabeth Moyano, Laura Torras-Claveria (2021) - Physiologia plantarum -
Cardioprotective Effect of Anisodamine Against Myocardial Ischemia Injury and its Influence on Cardiomyocytes Apoptosis.
Kun Xing, Xianghua Fu, Lingling Jiang, Yanbo Wang, Wei Li, Xinshun Gu, Guozhen Hao, Qing Miao, Xiaolin Ge, Yuhong Peng, Wei Geng, Shiru Bai, Liye Wei, Xile Bi (2015) - Cell biochemistry and biophysics -
Viral inhibitory potential of hyoscyamine in Japanese encephalitis virus-infected embryonated chicken eggs involving multiple signaling pathways.
Arghyadeep Bhattacharjee, Rahul Naga, Manish Saha, Srabani Karmakar, Abhishek Pal, Souvik Roy (2023) - Archives of virology -
Antiviral and anti-inflammatory activity of novel belladonna formulation against Japanese encephalitis virus via inhibition of p65 nuclear translocation and TNF-α mediated NF-kB signaling.
Shailendra K Saxena, Swatantra Kumar, Vimal K Maurya, Debadatta Nayak, Subhash Kaushik, Raj K Manchanda, Srinivasulu Gadugu (2023) - Biotechnology & genetic engineering reviews -
Anisodamine Ameliorates Hyperkalemia during Crush Syndrome through Estradiol-Induced Enhancement of Insulin Sensitivity.
Jian-Guang Yu, Bo-Shi Fan, Jin-Min Guo, Yun-Jie Shen, Ye-Yan Hu, Xia Liu (2019) - Frontiers in pharmacology -
Indian traditional medicinal plants in ophthalmic diseases.
Sana Nafees, Jamal Akhtar, Jasbir Kaur (2022) - Avicenna journal of phytomedicine -
Randomized controlled trial of postoperative belladonna and opium rectal suppositories in vaginal surgery.
Kristina Butler, John Yi, Megan Wasson, Jennifer Klauschie, Debra Ryan, Joseph Hentz, Jeffrey Cornella, Paul Magtibay, Roseanne Kho (2017) - American journal of obstetrics and gynecology -
Action of antibiotic oxacillin on in vitro growth of methicillin-resistant Staphylococcus aureus (MRSA) previously treated with homeopathic medicines.
Tânia Aguiar Passeti, Leandro Ribeiro Bissoli, Ana Paula Macedo, Registila Beltrame Libame, Susana Diniz, Silvia Waisse (2017) - Homeopathy : the journal of the Faculty of Homeopathy -
Acute angle closure glaucoma precipitated by homeopathic eyedrops containing Atropa belladonna.
Mallorie L Huff, Derek Fikse, Ryan M Surmaitis, Marna Rayl Greenberg (2022) - The American journal of emergency medicine
This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!